Professional Documents
Culture Documents
Experimental Study Designs
Experimental Study Designs
DESIGNS
Kiran Mishra
MSc Part II
Sem 3 Paper 1
009
INTRODUCTION TO RESEARCH DESIGN
• Unbiased study
• Example:
-A Pilot of a Randomized Control Trial of Melatonin and Vitamin C for Mild-to-Moderate COVID-19 (effect of dietary
supplements on symptom course and quality of life in patients)
- 3 arm study –
1. Control group (n=34)
2. Vitamin C – 1000mg (n=32)
3. Melatonin – 1o mg (n=32)
- All supplements taken for 14 days
• Allocation concealment
• Blinding
• Compliance
• Co-intervention
NON RANDOMIZED RCT
• Prone to bias
• No randomization
• Depends on researcher/patient
• Example: Implementation Evaluation of a Cluster Randomized Controlled Trial to Promote the Use of Respiratory
Protective Equipment Among Migrant Workers Exposed to Organic Solvents in Small and Medium-Sized Enterprises
(SMEs)
- 60 SMEs -> random allocation to a low- or high-intensive intervention group, or a control group.
- The low-intensive intervention group was subjected to both traditional and Health occupational health education.
- The high-intensive intervention group was subjected to the low-intensive group activities and peer education.
- Conclusion: A multi-component occupational health intervention to promote the use of RPE among workers in SMEs was
feasible and acceptable. Peer education had great potential to enhance implementation of use of RPE.
FACTORIAL DESIGNS
• allows the study of two interventions in the same trial without unduly increasing the required number of participants.
• Allows study of interaction between both the interventions
• Example
- In a study, infants in south India being administered a rotavirus vaccine were randomly assigned to receive a zinc
supplement and a probiotic, only probiotic (with zinc placebo), only zinc supplement (with probiotic placebo), or neither
(probiotic placebo and zinc placebo)
- Conclusion:
- Neither zinc nor probiotic led to any change in the immunogenicity of the vaccine
- The group receiving the zinc-probiotic combination had a modest improvement
CROSSOVER STUDY DESIGN
• A special type of study designs – participants intentionally crossover to the other arm
• Washout period between the crossover
• Advantages:
• Self controls
• Compensation for failed randomization.
• Limitations:
• More advantageous over RCT but is not possible in all conditions (if disease is curable)
• Example:
-In healthy adults resistant maltodextrin produces a greater change in fecal Bifidobacteria counts and increases stool wet
weight: a double-blind, randomized, controlled crossover study.
- 51 participants were randomized to consume
0g of RMD (25g of maltodextrin)
15 g RMD (15 g RMD and 10 g maltodextrin) and
25 g RMD
- Followed by a 2-week washout.
- Participants collected all stools for 2 days at weeks 0 and 3 of each intervention for stool wet weight (WW)
measurements and fecal Bifidobacteria counts.
- Conclusion: RMD was well tolerated and allowed individuals who typically consume an inadequate fiber diet to exceed
recommendations for total daily fiber intake. Gastrointestinal symptom data suggested that both 15 g and 25 g of RMD
were fermented, whereas only 25 g of RMD resulted in a greater change in Bifidobacteria and an increase in stool WW.
PRETEST POSTTEST DESIGN
- Study Design:
- 25 schools – with at least 100 students per school who are available to take the intervention, and are regularly enrolled in
the school.
- Children self reported who all took part in the mass drug administration campaign.
- Control was also done on the basis of children who denied participation in the mass drug campaign
- Conclusion:
-> In the present cohort of Haitian children, antibody responses against ETR51 were rapidly affected by a tMDA campaign
using primaquine.
-> Seropositivity to ETR51 was significantly reduced in the 2–6 weeks following the intervention, confirming its usefulness
as a short-term marker in child populations.
INTERVENTIONAL STUDIES WITHOUT CONCURRENT CONTROLS
• Historical Control
• Design is limited to the testing population, variations are expected across the globe.
2. Thiese MS. 2014. Observational and interventional study design types; an overview. Biochem Medica 24:199–210.
3. Inaam Akhtar. 2016. Research DesignResearch in Social Science: Interdisciplinary PerspectivesFirst. Social research foundation,
Kanpur, India.
4. C.R. Kothari. Research Methodology - Methods & TechniquesSecond. NEW AGE INTERNATIONAL (P) LIMITED, PUBLISHERS.
6. Aggarwal R, Ranganathan P. 2019. Study designs: Part 4 – Interventional studies. Perspect Clin Res 10:137.
7. Siepmann T, Spieth PM, Kubasch AS, Penzlin AI, Illigens BM-W, Barlinn K. 2016. Randomized controlled trials - a matter of design.
Neuropsychiatr Dis Treat 1341.
8. Fogleman C, Cohen D, Mercier A, Farrell D, Rutz J, Bresz K, Vernon T. 2022. A Pilot of a Randomized Control Trial of Melatonin and
Vitamin C for Mild-to-Moderate COVID-19. J Am Board Fam Med 35:695–707.
9. Burns AM, Solch RJ, Dennis-Wall JC, Ukhanova M, Nieves C, Mai V, Christman MC, Gordon DT, Langkamp-Henken B. 2018. In
healthy adults, resistant maltodextrin produces a greater change in fecal bifidobacteria counts and increases stool wet weight: a double-
blind, randomized, controlled crossover study. Nutr Res 60:33–42.
10. Machin D, Fayers PM, Tai BC. 2021. Randomised Clinical Trials - Design, Practice and ReportingSecond. Wiley Blackwell.
11. Devereaux PJ. 2001. Physician Interpretations and Textbook Definitions of Blinding Terminology in Randomized Controlled Trials. JAMA
285:2000.
12. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, McQuay HJ. 1996. Assessing the quality of reports of
randomized clinical trials: Is blinding necessary? Control Clin Trials 17:1–12.
13. Moher D, Schulz KF, Altman DG. 2001. The CONSORT statement: revised recommendations for improving the quality of reports of parallel
group randomized trials. BMC Med Res Methodol 1:2.
14. Jittat N, Pongpirul K, Tepwituksakit B, Iammaleerat P, Heath J, Lungchukiet P, Taechakraichana N, Charukitpipat A. 2022. Effects of Oral
Multi-Vitamin Multi-Mineral Supplement Formulations on Laboratory Outcomes and Quality of Life: A Quasi-Experimental Study. Front Nutr
9:889910.
15. Druetz T, van den Hoogen L, Stresman G, Joseph V, Hamre KES, Fayette C, Monestime F, Presume J, Romilus I, Mondélus G, Elismé T,
Cooper S, Impoinvil D, Ashton RA, Rogier E, Existe A, Boncy J, Chang MA, Lemoine JF, Drakeley C, Eisele TP. 2022. Etramp5 as a useful
serological marker in children to assess the immediate effects of mass drug campaigns for malaria. BMC Infect Dis 22:643.
16. Elsewedy HS, Shehata TM, Soliman WE. 2022. Tea Tree Oil Nanoemulsion-Based Hydrogel Vehicle for Enhancing Topical Delivery of
Neomycin. Life 12:1011.
17. Lin C, Li T, Zou G, Li X, Ling L, Chen W. 2022. Implementation Evaluation of a Cluster Randomized Controlled Trial to Promote the Use of
Respiratory Protective Equipment Among Migrant Workers Exposed to Organic Solvents in Small and Medium-Sized Enterprises. Front Public
Health 10:772632.